Clinical Trials
26 trialsNCT03256916 2026-02-24
NELCER
Tata Memorial Hospital
Phase 3 Completed
NCT03738228 2025-11-12
Atezolizumab Before and/or With Chemoradiotherapy in Immune System Activation in Patients With Node Positive Stage IB2, II, IIIB, or IVA Cervical Cancer
National Cancer Institute (NCI)
Phase 1 Completed
NCT03298893 2025-09-19
NiCOL
Institut Curie
Phase 1/2 Completed
NCT01088347 2024-04-19
Mapatumumab, Cisplatin and Radiotherapy for Advanced Cervical Cancer
University Medical Center Groningen
Phase 1/2 Completed
NCT04551950 2024-03-08
Bintrafusp Alfa Combination Therapy in Participants With Cervical Cancer (INTR@PID 046)
EMD Serono
Phase 1 Completed
NCT01991808 2019-11-26
Suitability of DCE-MRI for Detection of Vascular Changes After VBT
Abramson Cancer Center at Penn Medicine
Phase NA Completed
NCT00287911 2017-12-02
Topotecan, Cisplatin, and Radiation Therapy in Treating Patients With Advanced Cervical Cancer
Masonic Cancer Center, University of Minnesota
Phase 1 Completed
NCT00003704 2016-07-06
Chemotherapy Plus Radiation Therapy in Treating Patients With Unresectable, Residual, or Recurrent Colorectal Cancer
Alliance for Clinical Trials in Oncology
Phase 1 Completed
NCT00068549 2014-12-25
Radiation Therapy Plus Cisplatin and Gemcitabine in Treating Patients With Cervical Cancer
GOG Foundation
Phase 1 Completed
NCT00023660 2013-11-19
Radiation Therapy Plus Celecoxib, Fluorouracil, and Cisplatin in Patients With Locally Advanced Cervical Cancer
Radiation Therapy Oncology Group
Phase 1/2 Completed
NCT01937650 2013-09-09
Radiotherapy + Metronidazole vs Radiotherapy Alone In Improving Treatment Outcomes in Advanced Cervical Cancer in Uganda
Makerere University
Phase 2/3 Completed
NCT00002949 2013-09-05
Vinorelbine and Paclitaxel Plus Radiation Therapy in Treating Patients With Advanced Cancer Arising in the Pelvis
University of Chicago
Phase 1 Completed
NCT00002536 2013-07-09
Surgery With or Without Chemotherapy in Treating Patients With Stage IB Cervical Cancer
GOG Foundation
Phase 3 Completed
NCT00003078 2013-07-09
Radiation Therapy With or Without Cisplatin or Fluorouracil in Treating Patients With Cancer of the Cervix
GOG Foundation
Phase 3 Completed
NCT00098995 2013-06-26
Tirapazamine, Cisplatin, and Radiation Therapy in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer
National Cancer Institute (NCI)
Phase 1 Completed
NCT00278304 2013-06-20
Radiation Therapy in Treating Patients With Cervical Cancer
National Cancer Institute (NCI)
Phase 2 Completed
NCT00046969 2013-05-30
Epoetin Beta in Treating Anemia in Patients With Cervical Cancer
National Cancer Institute (NCI)
Phase 4 Completed
NCT00003379 2013-05-27
Radiation Therapy Plus Paclitaxel and Cisplatin in Treating Patients With Cervical Cancer
GOG Foundation
Phase 1/2 Completed
NCT00003377 2013-02-04
Radiation Therapy, Paclitaxel, and Cisplatin in Treating Patients With Cancer of the Cervix
GOG Foundation
Phase 1 Completed
NCT00003209 2012-07-11
Radiation Therapy With or Without Chemotherapy After Surgery in Treating Patients With Stage IB or Stage IIA Cervical Cancer
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3 Completed
NCT00002916 2012-07-02
Surgery and Vaccine Therapy in Treating Patients With Early Cervical Cancer
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2 Completed
NCT00122772 2011-10-14
CRP on Radiobiological and Clinical Studies on Viral-Induced Cancer's Response to Radiotherapy
International Atomic Energy Agency
Phase 3 Completed
NCT01262144 2010-12-17
SUV Max as Predictor of Outcome in Cervical Cancer
Rambam Health Care Campus
Completed
NCT00005941 2010-04-02
Peripheral Stem Cell Transplant, White Blood Cell Infusions, Chemotherapy, and Radiation Therapy in Treating Patients With Recurrent Metastatic Cervical or Vaginal Cancer
Fred Hutchinson Cancer Center
Phase 2 Completed
NCT00165126 2009-11-02
Dosimetric Analysis of Vaginal Cuff Brachytherapy in Endometrial Carcinoma
Dana-Farber Cancer Institute
Completed
NCT00178269 2009-05-19
Low-Dose Taxotere® (Docetaxel) With Concurrent Radiotherapy For Localized, Inoperable Carcinoma Of The Uterine Cervix
University of Rochester
Phase 2 Completed